Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Yahoo India News
Washington [US], September 28 (ANI): Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart dise…
Continue Reading
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM